PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS

The Lancet

Volumn 322, Issue 8358, 1983, Pages 1043-1046

  Teasley, DavidG ^a   Olson, MaryM ^a   Gebhard, RogerL ^a   Gerding, DaleN ^a   Peterson, LanceR ^a   Schwartz, MichaelJ ^a   Lee Jr , JamesT ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ADVERSE DRUG REACTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLITIS; CONTROLLED STUDY; DIARRHEA; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; ENDOSCOPY; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; LARGE INTESTINE; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PSEUDOMEMBRANOUS COLITIS; RANDOMIZED CONTROLLED TRIAL; THERAPY; TRIAL; VOMITING;

ADULT; AGED; CLINICAL TRIALS; CLOSTRIDIUM INFECTIONS; COLITIS; COSTS AND COST ANALYSIS; DIARRHEA; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOM ALLOCATION; VANCOMYCIN;

EID: 0021038539     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(83)91036-X     Document Type: Article

References (28)

1. Aetiology of antimicrobial-agent-associated colitis
2. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
3. Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin
4. Pseudomembranous colitis: presence of clostridial toxin
5. Antibiotic-associated pseudomembranous colitis
6. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions
7. Treatment of antibiotic-associated enterocolitis with vancomycin
8. Oral vancomycin for antibiotic-associated pseudomembranous colitis
9. Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis
10. Treatment of Clostridium difficile colitis and diarrhea with vancomycin
11. Relapse of pseudomembranous colitis after vancomycin therapy
12. Toxigenicity and antimicrobial susceptibility of Clostridium difficile, a cause of antimicrobial agent-associated colitis
13. In vitro susceptibility of Clostridium difficile isolated from patients with antibiotic-associated diarrhea or colitis
14. Oral metronidazole in Clostridium difficile colitis
15. Metronidazole: An alternate therapy for antibiotic-associated colitis
16. Colitis associated with metronidazole therapy
17. Pseudomembranous colitis after treatment with metromdazole
18. Selective and differential medium for isolation of Clostridium difficile
19. Prospective study of Gram stain stool smears in diagnosis of Clostridium difficile
20. Isolation of Clostridium difficile from hospitalized patients without antibiotic associated diarrhea or colitis
21. Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination
22. Metronidazole
23. Excretion of metronidazole in human bile
24. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn's disease
25. Metronidazole: Proven benefits and potential risks
26. Lack of evidence for cancer due to use of metronidazole
27. Is vancomycin overpriced?